New combo therapy aims to extend life in elderly esophageal cancer patients
Disease control
Not yet recruiting
This study tests a combination of the chemotherapy drug TAS-102 and radiation therapy in people aged 65-85 with advanced esophageal cancer that has not spread widely. The goal is to find the best dose and see if the treatment helps patients live longer and controls the cancer. Ab…
Phase: PHASE1, PHASE2 • Sponsor: Qianfoshan Hospital • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC